Ciuffreda Kenneth J, Rutner Daniella, Kapoor Neera, Suchoff Irwin B, Craig Shoshana, Han M E
State University of New York State College of Optometry, Raymond J Greenwald Rehabilitation Center, New York, NY 10036, USA.
Optometry. 2008 Jan;79(1):18-22. doi: 10.1016/j.optm.2007.10.004.
Oculomotor dysfunctions are among the most common abnormalities found in the brain-injured population. The purpose of the current study was to determine retrospectively the effectiveness of conventional optometric vision therapy for oculomotor disorders of vergence and version in a sample of ambulatory, visually symptomatic, predominantly adult outpatients who had either mild traumatic brain injury (TBI) or cerebrovascular accident (CVA).
A computer-based query for acquired brain injury patients examined between the years of 2000 and 2003 was conducted in our clinic. This yielded 160 individuals with mild TBI and 60 with CVA. Of these patients, only those for whom vision therapy was prescribed and who completed an optometric vision therapy program for remediation of their oculomotor dysfunctions were selected. This included 33 with TBI and 7 with CVA. The criterion for treatment success was denoted by marked/total improvement in at least 1 primary symptom and at least 1 primary sign.
Ninety percent of those with TBI and 100% of those with CVA were deemed to have treatment success. These improvements remained stable at retesting 2 to 3 months later.
Nearly all patients in the current clinic sample exhibited either complete or marked reduction in their oculomotor-based symptoms and improvement in related clinical signs, with maintenance of the symptom reduction and sign improvements at the 2- to 3-month follow-up. These findings show the efficacy of optometric vision therapy for a range of oculomotor abnormalities in the primarily adult, mild brain-injured population. Furthermore, it shows considerable residual neural plasticity despite the presence of documented brain injury.
眼球运动功能障碍是脑损伤人群中最常见的异常情况之一。本研究的目的是回顾性地确定传统验光视觉疗法对一组以门诊为主、有视觉症状、主要为成年患者的眼球运动性聚散和转位障碍的有效性,这些患者患有轻度创伤性脑损伤(TBI)或脑血管意外(CVA)。
对2000年至2003年间在我们诊所接受检查的后天性脑损伤患者进行基于计算机的查询。这产生了160例轻度TBI患者和60例CVA患者。在这些患者中,仅选择那些被开了视觉疗法处方并完成了验光视觉疗法程序以纠正其眼球运动功能障碍的患者。这包括33例TBI患者和7例CVA患者。治疗成功的标准是至少1项主要症状和至少1项主要体征有显著/完全改善。
90%的TBI患者和100%的CVA患者被认为治疗成功。在2至3个月后的重新测试中,这些改善保持稳定。
在当前诊所样本中,几乎所有患者的眼球运动相关症状均完全或显著减轻,相关临床体征有所改善,并且在2至3个月的随访中症状减轻和体征改善得以维持。这些发现表明验光视觉疗法对主要为成年轻度脑损伤人群的一系列眼球运动异常有效。此外显示,尽管存在已记录的脑损伤,但仍有相当大的残余神经可塑性。